New Dimensions Day Treatment Centers

Club Drug Use and Associated Risks

Jul 9, 2025 | Addiction, Drug Usage Archives

Club drugs are commonly used at events like raves, parties, concerts, and nightclubs, where high-energy environments, dancing, and elaborate light shows are central. These drugs are often taken to enhance sensory perception, sociability, and feelings of euphoria. Many club drugs stimulate empathy and energy, enabling users to engage more fully in social experiences (National Institute on Drug Abuse [NIDA], 2017).

Despite their popularity, these substances carry significant risks. Club drugs are frequently produced in unregulated labs and may be adulterated with unknown chemicals, increasing the risk of overdose or harmful bodily effects. The combination of stimulant use, dehydration from prolonged dancing, and hot venues further elevates health risks (Drug Enforcement Administration [DEA], 2020).

Common Club Drugs and Their Risks

MDMA (Ecstasy): MDMA is a widely used stimulant with psychoactive effects, known for inducing euphoria, empathy, and sensory enhancement. However, it is often mixed with other drugs when sold as ecstasy, increasing risks. Adverse effects may include dehydration, hyperthermia, anxiety, irregular heartbeat, and poor judgment (NIDA, 2017).

Ketamine: Initially used as an anesthetic, ketamine induces dissociation and hallucinations at higher doses. Known for causing a “k-hole” — a state of paralysis and detachment — it is also linked to sexual assault due to its sedative effects. Side effects include confusion, irregular heartbeat, chest pain, and difficulty speaking or moving (DEA, 2020).

LSD: LSD is a powerful hallucinogen that alters perception and reality. While overdoses are rare, users can experience severe psychological effects like paranoia, panic attacks, or psychosis. Its use in club settings can lead to sensory overload and dangerous behavior, especially during a “bad trip” (NIDA, 2019).

GHB: GHB has euphoric and sociability-enhancing effects but is dangerous in high doses. It’s used medically to treat narcolepsy, yet recreational misuse can cause sedation, memory loss, and respiratory depression. As a colorless, tasteless liquid, it’s easily mixed into drinks, making it a frequent date-rape drug (DEA, 2020).

Rohypnol: A potent benzodiazepine, Rohypnol causes sedation, impaired coordination, and memory loss. Like GHB, it’s often associated with sexual assault. Combining it with alcohol or other depressants significantly increases overdose risk (NIDA, 2021).

Methamphetamine: Known as meth or crystal meth, this highly addictive stimulant offers prolonged energy but causes serious physical and mental damage, including paranoia, hallucinations, mood swings, and dental issues. The combination of meth with prolonged activity and heat exposure at clubs intensifies health hazards (Substance Abuse and Mental Health Services Administration [SAMHSA], 2018).

Treatment and Prevention

Although most club drugs are not classified as highly addictive (except meth and Rohypnol), they can still lead to psychological dependence and risky behavior. Professional substance abuse treatment is often necessary to address underlying issues and prevent long-term harm.

New Dimensions Can Help!

New Dimensions Day Treatment Centers offer Intensive Outpatient Programs for substance use disorders.  These treatment programs are a vital and flexible component of the continuum of care for substance use treatment. They provide a structured, evidence-based approach that allows individuals to recover while maintaining community, work, and family ties. For those not requiring inpatient services, IOPs offer a proven pathway to achieving and sustaining recovery.  To learn more about New Dimensions Intensive Outpatient Programs to treat substance use disorders, call 1-800-685-9796 or go to our website:  www.nddtreatment.com.

References

Drug Enforcement Administration. (2020). Drugs of abuse: A DEA resource guide. https://www.dea.gov/documents/2020/2020-04/2020-drugs-abuse

National Institute on Drug Abuse. (2017). MDMA (Ecstasy/Molly) drug facts. https://nida.nih.gov/publications/drugfacts/mdma-ecstasymolly

National Institute on Drug Abuse. (2019). LSD (Acid) drug facts. https://nida.nih.gov/publications/drugfacts/hallucinogens-lsd-peyote-psilocybin-pcp

National Institute on Drug Abuse. (2021). Benzodiazepines and opioids. https://nida.nih.gov/publications/research-reports/benzodiazepines

Substance Abuse and Mental Health Services Administration. (2018). Methamphetamine. https://www.samhsa.gov/meth